Researchers
Boljević, Ivana
Results 21-40 of 50
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2019 | High expression of junctional adhesion molecule-A is associated with poor survival in patients with epithelial ovarian cancer | Boljević, Ivana  ; Mališić, Emina  ; Marijana, Milovic-Kovacevic ; Irena, Jovanic; Zoran, Bukumiric ; Radmila, Jankovic | Article | 22M22 |
| 2019 | Molecular prediction of chronic myeloid leukemia risk and resistance to imatinib. | Jankovic, Radmila ; Krivokuca, Ana ; Boljević, Ivana ; Radulovic, Sinisa ; Čavić, Milena | Conference Paper | Mp. category will be shown later |
| 2019 | The implementation of somatic BRCA1/2 testing in advanced ovarian cancer patients: Serbian experience | Boljević, Ivana Ž. ; Krivokuća A; Rakobradović, Jelena D. ; Tanić, Miljana G. ; Janković R | Conference Paper | Mp. category will be shown later |
| 2019 | Discovery of the Biginelli hybrids as novel caspase-9 activators in apoptotic machines: Lipophilicity, molecular docking study, influence on angiogenesis gene and miR-21 expression levels | Janković, Nenad Ž. ; Trifunović Ristovski, Jovana ; Vraneš, Milan ; Tot, Aleksandar ; Petronijević, Jelena ; Joksimović, Nenad ; Stanojković, Tatjana P. ; Đorđić Crnogorac, Marija ; Petrović, Nina ; Boljević, Ivana ;
Matić, Ivana Z.
; Bogdanović, Goran A. ; Mikov, Momir ; Bugarčić, Zorica M. ; | Article | 21aM21a |
| 2019 | Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia | Krivokuća, Ana ; Boljević, Ivana ; Jovandic, Stevo; Magic, Zvonko ; Mandić, Aljoša ; Tomasevic, Zorica ; Brankovic-Magic, Mirjana | Article | 21M21 |
| 2019 | Tracking resistance to tyrosine kinase inhibitors (TKIs) by EGFR mutation testing from liquid biopsy of advanced lung adenocarcinoma patients | Jokić V; Spasić Jelena ; Krivokuća Ana ; Boljević, Ivana Ž. ; Kajzerberger, Marijana S. ; Rakobradović, Jelena D. ; Radosavljević, Davorin ; Radulović, Sinisa ; Mališić, Emina J. ; Janković Radmila ;
Čavić, Milena R.
; | Conference Paper | Mp. category will be shown later |
| 2019 | EGFR mutation testing of advanced lung adenocarcinoma patients in Serbia – advantages and setbacks of liquid biopsy testing in developing countries | Spasić, Jelena ; Krivokuća, Ana ; Boljević, Ivana Ž. ; Kajzerberger, Marijana S. ; Rakobradović, Jelena D. ; Jokić V; Radosavljević, Davorin ; Mališić, Emina J. ; Janković, Radmila ; Čavić, Milena R. | Conference Paper | Mp. category will be shown later |
| 2018 | TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool. | Čavić, Milena ; Spasic, Jelena ; Krivokuća, Ana ; Boljević, Ivana ; Kuburovic, Mira; Radosavljevic, Davorin ; Jankovic, Radmila | Article | 21M21 |
| 2017 | Expression of Cald1 Gene in Ovarian Cancer Pathogenesis | Boljević, Ivana Ž. ; Mališić, Emina J. ; Krivokuća, Ana M. ; Janković, Radmila N. | Conference Paper | Mp. category will be shown later |
| 2017 | The frequency of Ala91Val PRF1 germline mutation in Serbian breast and ovarian cancer patients | Krivokuća, Ana M. ; Boljević, Ivana Ž. ; Rakobradović, Jelena D. ; Branković-Magić, Mirjana V. | Conference Paper | Mp. category will be shown later |
| 2017 | Germline mutations in breast and ovarian cancer cases from Serbia | Krivokuća, Ana M. ; Boljević, Ivana Ž. ; Rakobradović, Jelena D. ; S. Jovandić; Branković-Magić, Mirjana V. | Conference Paper | Mp. category will be shown later |
| 2017 | Expression of integrin alpha V gene in epithelial ovarian cancer pathogenesis | Boljević, Ivana Ž. ; Mališić, Emina J. ; Jovanić, Irena; Janković, Radmila N. | Conference Paper | Mp. category will be shown later |
| 2017 | Novel germline mutation in MSH2 gene and the challenges of genetic counseling | Rakobradović, Jelena D. ; Krivokuća, Ana M. ; Boljević, Ivana Ž. ; Kesić, Vesna I. ; Branković-Magić, Mirjana V. | Conference Paper | Mp. category will be shown later |
| 2017 | Detekcija nasledne predispozicije za karcinom dojke i jajnika metodom nove generacije sekvenciranja -prvi rezultati u Srbiji | Krivokuća, Ana M. ; Boljević, Ivana Ž. ; Rakobradović, Jelena D. ; S. Jovandić; Branković-Magić, Mirjana V. | Conference Paper | Mp. category will be shown later |
| 2017 | Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin | Krivokuća, Ana ; Dragos, Vita Setrajcic; Stamatovic, Ljiljana ; Blatnik, Ana; Boljević, Ivana ; Stegel, Vida; Rakobradović, Jelena ; Skerl, Petra; Jovandic, Stevo; Krajc, Mateja;
Branković-Magić, Mirjana
; Novakovic, Srdjan; | Article | 22M22 |
| 2016 | Pharmacogenetics in cancer therapy-8 years of experience at the Institute for Oncology and Radiology of Serbia | Cavić, Milena ; Krivokuca, Ana ; Boljević, Ivana ; Brotto, Ksenija; Jovanović, Katarina; Tanić, Miljana ; Filipović, Lana ; Zec, Manja M. ; Malisić, Emma ; Janković, Radmila ;
Radulović, Siniša
; | Article | 23M23 |
| 2016 | Expression of the epithelial- mesenchymal transition related genes ITGAV and F11R in ovarian tumorigenesis | Mališić, Emina ; Boljević, Ivana ; Krivokuća, Ana ; Janković, Radmila | Conference Paper | Mp. category will be shown later |
| 2016 | Farmacogenomics tests in solid tumors | Boljević, Ivana | Conference Paper | Mp. category will be shown later |
| 2016 | Five gene predictor of genitourinary and gastrointestinal toxicity after three dimensional conformal radiotherapy (3DCRT) for localized prostate cancer | Janković, Radmila ; Boljević, Ivana ; Mališić, Emina ; Stanković, Vesna ; Nikitović, Marina ; Radulović, Siniša | Conference Paper | Mp. category will be shown later |
| 2016 | DNA repair gene polymorphisms as risk factors and chemotherapy response predictors for lung adenocarcinoma in Serbia | Boljević, Ivana | Conference Paper | Mp. category will be shown later |